Beta Glucosylceramide for Treatment of NASH

NCT02126306 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Compliance Behavior

Interventions

DRUG: Beta Glucosylceramide
DRUG: Placebo

Sponsor

Hadassah Medical Organization